Risk Stratification for Bleeding in the Elderly with Acute Coronary Syndrome: Not So Simple

References
1 Roffi M, Patrono C, Collet J-P. , et al; ESC Scientific Document Group. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016; 37 (03) 267-315
2 Sibbing D, Angiolillo DJ, Huber K. Antithrombotic therapy for acute coronary syndrome: past, present and future. Thromb Haemost 2017; 117 (07) 1240-1248
3 Valgimigli M, Bueno H, Byrne RA. , et al. ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur Heart J 2018; 39 (03) 213-260
4 Capodanno D, Angiolillo DJ. Triple antithrombotic therapy at the intercept between threats and opportunities: don't throw out the baby with the bath water. JACC Cardiovasc Interv 2017; 10 (11) 1086-1088
5 Capodanno D, Angiolillo DJ. Antithrombotic pharmacotherapy in the elderly: general issues and clinical conundrums. Curr Treat Options Cardiovasc Med 2012; 14 (01) 57-68
6 Mathews R, Peterson ED, Chen AY. , et al. In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry®-GWTG™. Am J Cardiol 2011; 107 (08) 1136-1143
7 Subherwal S, Bach RG, Chen AY. , et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score. Circulation 2009; 119 (14) 1873-1882
8 Mehran R, Pocock SJ, Nikolsky E. , et al. A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol 2010; 55 (23) 2556-2566
9 Yeh RW, Secemsky EA, Kereiakes DJ. , et al; DAPT Study Investigators. Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention. JAMA 2016; 315 (16) 1735-1749
10 Baber U, Mehran R, Giustino G. , et al. Coronary thrombosis and major bleeding after PCI with drug-eluting stents: risk scores from PARIS. J Am Coll Cardiol 2016; 67 (19) 2224-2234
11 Costa F, van Klaveren D, James S. , et al; PRECISE-DAPT Study Investigators. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet 2017; 389 (10073): 1025-1034
12 Raposeiras-Roubín S, Faxén J, Íñiguez-Romo A. , et al. Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: the BleeMACS score. Int J Cardiol 2018; 254: 10-15
13 Capodanno D, Angiolillo DJ. Tailoring duration of DAPT with risk scores. Lancet 2017; 389 (10073): 987-989
14 Abu-Assi E, Raposeiras-Roubin S, Cobas-Paz R. , et al. Assessing the performance of the PRECISE-DAPT and PARIS risk scores for predicting 1-year out-of-hospital bleeding in acute coronary syndrome patients. EuroIntervention 2018; 13 (16) 1914-1922
15 Garay A, Ariza-Solé A, Formiga F. , et al. Prediction of post-discharge bleeding in elderly patients with acute coronary syndromes: insights from the BleeMACS registry. Thromb Haemost 2018; 118 (05) 929-938
16 Ariza-Solé A, Guerrero C, Formiga F. , et al. Global geriatric assessment and in-hospital bleeding risk in elderly patients with acute coronary syndromes: insights from the LONGEVO-SCA Registry. Thromb Haemost 2018; 118 (03) 581-590
17 Alegre O, Ariza-Solé A, Vidán MT. , et al. Impact of frailty and other geriatric syndromes on clinical management and outcomes in elderly patients with non-ST-segment elevation acute coronary syndromes: rationale and design of the LONGEVO-SCA Registry. Clin Cardiol 2016; 39: 373-377
18 Capodanno D, Angiolillo DJ. Antithrombotic therapy in the elderly. J Am Coll Cardiol 2010; 56 (21) 1683-1692
19 Urban P, Meredith IT, Abizaid A. , et al; LEADERS FREE Investigators. Polymer-free drug-coated coronary stents in patients at high bleeding risk. N Engl J Med 2015; 373 (21) 2038-2047
20 Varenne O, Cook S, Sideris G. , et al; SENIOR investigators. Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial. Lancet 2018; 391 (10115): 41-50
21 Lip GYH, Lane DA. Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores. J Thromb Haemost 2016; 14 (09) 1711-1714